Published 6 September 2005. doi:10.1084/jem.20050607
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 5, 663-671
MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells
Sergey Filippov1,
Gerald C. Koenig2,
Tae-Hwa Chun1,
Kevin B. Hotary1,
Ichiro Ota1,
Thomas H. Bugge3,
Joseph D. Roberts2,
William P. Fay2,
Henning Birkedal-Hansen4,
Kenn Holmbeck4,
Farideh Sabeh1,
Edward D. Allen1, and
Stephen J. Weiss1
1 Division of Molecular Medicine and Genetics, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109
2 Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109
3 Protease and Tissue Remodeling Unit, National Institute of Dental and Craniofacial Research, Bethesda, MD 20892
4 Matrix Metalloproteinase Unit, National Institute of Dental and Craniofacial Research, Bethesda, MD 20892
CORRESPONDENCE Stephen J. Weiss: sjweiss{at}umich.edu
During pathologic vessel remodeling, vascular smooth muscle cells (VSMCs) embedded within the collagen-rich matrix of the artery wall mobilize uncharacterized proteolytic systems to infiltrate the subendothelial space and generate neointimal lesions. Although the VSMC-derived serine proteinases, plasminogen activator and plasminogen, the cysteine proteinases, cathepsins L, S, and K, and the matrix metalloproteinases MMP-2 and MMP-9 have each been linked to pathologic matrix-remodeling states in vitro and in vivo, the role that these or other proteinases play in allowing VSMCs to negotiate the three-dimensional (3-D) cross-linked extracellular matrix of the arterial wall remains undefined. Herein, we demonstrate that VSMCs proteolytically remodel and invade collagenous barriers independently of plasmin, cathepsins L, S, or K, MMP-2, or MMP-9. Instead, we identify the membrane-anchored matrix metalloproteinase, MT1-MMP, as the key pericellular collagenolysin that controls the ability of VSMCs to degrade and infiltrate 3-D barriers of interstitial collagen, including the arterial wall. Furthermore, genetic deletion of the proteinase affords mice with a protected status against neointimal hyperplasia and lumen narrowing in vivo. These studies suggest that therapeutic interventions designed to target MT1-MMP could prove beneficial in a range of human vascular disease states associated with the destructive remodeling of the vessel wall extracellular matrix.
Abbreviations used: 2-D, two-dimensional; 3-D, three- dimensional; BrdU, bromodeoxyuridine; FGF, fibroblast growth factor; MMP, matrix metalloproteinase; MT1, membrane type I; PCNA, proliferating cell nuclear antigen; PDGF, platelet-derived growth factor; TIMP, tissue inhibitor of metalloproteinases; VSMC, vascular smooth muscle cell.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Lehti, K., Rose, N. F., Valavaara, S., Weiss, S. J., Keski-Oja, J.
(2009). MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J. Cell Sci.
122: 126-135
[Abstract]
[Full Text]
-
Li, X.-Y., Ota, I., Yana, I., Sabeh, F., Weiss, S. J.
(2008). Molecular Dissection of the Structural Machinery Underlying the Tissue-invasive Activity of Membrane Type-1 Matrix Metalloproteinase. Mol. Biol. Cell
19: 3221-3233
[Abstract]
[Full Text]
-
Cho, J.-A., Osenkowski, P., Zhao, H., Kim, S., Toth, M., Cole, K., Aboukameel, A., Saliganan, A., Schuger, L., Bonfil, R. D., Fridman, R.
(2008). The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP. J. Biol. Chem.
283: 17391-17405
[Abstract]
[Full Text]
-
Itoh, Y., Ito, N., Nagase, H., Seiki, M.
(2008). The Second Dimer Interface of MT1-MMP, the Transmembrane Domain, Is Essential for ProMMP-2 Activation on the Cell Surface. J. Biol. Chem.
283: 13053-13062
[Abstract]
[Full Text]
-
D'Alessio, S., Ferrari, G., Cinnante, K., Scheerer, W., Galloway, A. C., Roses, D. F., Rozanov, D. V., Remacle, A. G., Oh, E.-S., Shiryaev, S. A., Strongin, A. Y., Pintucci, G., Mignatti, P.
(2008). Tissue Inhibitor of Metalloproteinases-2 Binding to Membrane-type 1 Matrix Metalloproteinase Induces MAPK Activation and Cell Growth by a Non-proteolytic Mechanism. J. Biol. Chem.
283: 87-99
[Abstract]
[Full Text]
-
Partridge, J. J., Madsen, M. A., Ardi, V. C., Papagiannakopoulos, T., Kupriyanova, T. A., Quigley, J. P., Deryugina, E. I.
(2007). Functional Analysis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Differentially Expressed by Variants of Human HT-1080 Fibrosarcoma Exhibiting High and Low Levels of Intravasation and Metastasis. J. Biol. Chem.
282: 35964-35977
[Abstract]
[Full Text]
-
Genis, L., Gonzalo, P., Tutor, A. S., Galvez, B. G., Martinez-Ruiz, A., Zaragoza, C., Lamas, S., Tryggvason, K., Apte, S. S., Arroyo, A. G.
(2007). Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells. Blood
110: 2916-2923
[Abstract]
[Full Text]
-
Cretu, A., Roth, J. M., Caunt, M., Akalu, A., Policarpio, D., Formenti, S., Gagne, P., Liebes, L., Brooks, P. C.
(2007). Disruption of Endothelial Cell Interactions with the Novel HU177 Cryptic Collagen Epitope Inhibits Angiogenesis. Clin. Cancer Res.
13: 3068-3078
[Abstract]
[Full Text]
-
Furmaniak-Kazmierczak, E., Crawley, S. W., Carter, R. L., Maurice, D. H., Cote, G. P.
(2007). Formation of Extracellular Matrix-Digesting Invadopodia by Primary Aortic Smooth Muscle Cells. Circ. Res.
100: 1328-1336
[Abstract]
[Full Text]
-
Yana, I., Sagara, H., Takaki, S., Takatsu, K., Nakamura, K., Nakao, K., Katsuki, M., Taniguchi, S.-i., Aoki, T., Sato, H., Weiss, S. J., Seiki, M.
(2007). Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J. Cell Sci.
120: 1607-1614
[Abstract]
[Full Text]
-
Watts, S. W., Rondelli, C., Thakali, K., Li, X., Uhal, B., Pervaiz, M. H., Watson, R. E., Fink, G. D.
(2007). Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. Am. J. Physiol. Heart Circ. Physiol.
292: H2438-H2448
[Abstract]
[Full Text]
-
Tellier, E., Negre-Salvayre, A., Bocquet, B., Itohara, S., Hannun, Y. A., Salvayre, R., Auge, N.
(2007). Role for Furin in Tumor Necrosis Factor Alpha-Induced Activation of the Matrix Metalloproteinase/Sphingolipid Mitogenic Pathway. Mol. Cell. Biol.
27: 2997-3007
[Abstract]
[Full Text]
-
Hotary, K., Li, X.-Y., Allen, E., Stevens, S. L., Weiss, S. J.
(2006). A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev.
20: 2673-2686
[Abstract]
[Full Text]
-
Bock, O., Neuse, J., Hussein, K., Brakensiek, K., Buesche, G., Buhr, T., Wiese, B., Kreipe, H.
(2006). Aberrant Collagenase Expression in Chronic Idiopathic Myelofibrosis Is Related to the Stage of Disease but Not to the JAK2 Mutation Status. Am. J. Pathol.
169: 471-481
[Abstract]
[Full Text]
-
Filippov, S., Koenig, G. C., Chun, T.-H., Hotary, K. B., Ota, I., Bugge, T. H., Roberts, J. D., Fay, W. P., Birkedal-Hansen, H., Holmbeck, K., Sabeh, F., Allen, E. D., Weiss, S. J.
(2005). MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. JCB
170: i12-i12
[Full Text]